Clinical Trials Logo
NCT number NCT03172598
Study type Interventional
Source Mitsubishi Tanabe Pharma Corporation
Contact Clinical Trials Information Desk, to prevent miscommunication,
Phone please email:
Email info@mt-pharma-eu.com
Status Recruiting
Phase Phase 2
Start date July 25, 2017
Completion date August 2018

Clinical Trial Summary

A Study to Investigate the Safety, Tolerability and Efficacy of Multiple Doses of MT-8554 in Subjects with Painful Diabetic Peripheral Neuropathy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms